KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
KAMADA LTD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026
$7.61−0.15 (-1.93%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 21.7
- Dividend yield
- –
KAMADA LTD revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable segments [Member] | $180.46M | $160.95M | $142.52M | $102.60K | $75.52M | $100.92M | $97.70M | $90.78M | $79.56M | $55.96M | 100.0% | +12.1% |
| Distribution [Member] | – | – | – | $26.74K | $28.12M | $32.33M | $29.49M | $23.69M | $23.27M | $21.54M | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proprietary Products [Member] | $156.21M | $141.45M | $115.46M | – | – | – | – | – | – | – | 86.6% | +10.4% |
| Proprietary Products [Member] | $156.21M | $141.45M | – | – | – | – | – | – | – | – | 86.6% | +10.4% |
| Distribution | $24.25M | $19.51M | $27.06M | – | – | – | – | – | – | – | 13.4% | +24.3% |
| Distribution [Member] | $24.25M | $19.51M | – | – | – | – | – | – | – | – | 13.4% | +24.3% |
| Revenues from distribution | – | – | $27.06M | $26.74M | $28.12M | – | – | – | – | – | – | – |
| Revenues from proprietary products | – | – | $115.46M | $102.60M | $75.52M | – | – | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S.A [Member] | $99.64M | $100.50M | $73.74M | $65.30M | $49.76M | $84.95M | $84.57M | $75.33M | $60.41M | – | 55.2% | -0.9% |
| Israel [Member] | $29.56M | $25.01M | $31.30M | $32.03M | $35.77M | $36.14M | $31.96M | $28.09M | $26.36M | – | 16.4% | +18.2% |
| Latin America [Member] | $24.22M | $18.61M | $12.93M | $11.29M | $9.13M | – | – | $3.99M | $5.25M | $4.22M | 13.4% | +30.2% |
| Canada | $10.81M | $9.46M | $11.16M | $10.56M | – | – | – | – | – | – | 6.0% | +14.3% |
| Europe [Member] | $9.45M | $4.94M | $7.09M | $5.28M | $5.68M | $4.46M | $4.70M | $3.59M | $5.35M | – | 5.2% | +91.4% |
| Asia [Member] | $6.72M | $2.38M | $6.15M | $4.58M | $3.17M | – | – | $3.34M | $4.98M | $3.03M | 3.7% | +182.8% |
| Others [Member] | $56.00K | $62.00K | $157.00K | $306.00K | $134.00K | $59.00K | $96.00K | $121.00K | $490.00K | – | 0.0% | -9.7% |
| United States | – | – | $73.74M | – | – | – | – | $75.33M | $60.41M | $40.59M | – | – |
| Israel | – | – | $31.30M | – | – | – | – | $28.09M | $26.36M | $25.34M | – | – |
| Europe [Member] | – | – | – | – | – | – | – | $3.59M | $5.35M | $3.83M | – | – |
| Others [Member] | – | – | – | – | – | – | – | $121.00K | $490.00K | $495.00K | – | – |
| Asia [Member] | – | – | $6.15M | – | $3.17M | $766.00K | $2.07M | $3.34M | $4.98M | – | – | – |
| Latin America [Member] | – | – | $12.93M | – | $9.13M | $6.87M | $3.79M | $3.99M | $5.25M | – | – | – |
| Europe [Member] | – | – | $7.09M | – | – | – | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Kamada's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.